ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Inc (RPHM)

18.20
0.00
( 0.00% )
Updated: 20:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
18.20
Bid
1.75
Ask
1.88
Volume
-
0.00 Day's Range 0.00
9.801 52 Week Range 87.40
Market Cap
Previous Close
18.20
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
164,780
Shares Outstanding
33,428,808
Dividend Yield
-
PE Ratio
-7.86
Earnings Per Share (EPS)
-2.32
Revenue
-
Net Profit
-77.39M

About Reneo Pharmaceuticals Inc

Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing ... Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
Reneo Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RPHM. The last closing price for Reneo Pharmaceuticals was $18.20. Over the last year, Reneo Pharmaceuticals shares have traded in a share price range of $ 9.801 to $ 87.40.

Reneo Pharmaceuticals currently has 33,428,808 shares outstanding. The market capitalization of Reneo Pharmaceuticals is $608.40 million. Reneo Pharmaceuticals has a price to earnings ratio (PE ratio) of -7.86.

RPHM Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10018.218.218.200CS
44.835.820895522413.41912.729239215.47183724CS
123.523.809523809514.71912.50116478015.08971237CS
261.16.4327485380117.119.312.50120636715.85907892CS
52-56.2-75.537634408674.487.49.80141920520.11859923CS
156-46.4-71.82662538764.6112.959.80119206230.72268003CS
260-134.8-88.1045751634153168.39.80117597235.91555678CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TVGNTevogen Bio Holdings Inc
$ 1.18
(210.85%)
153.43M
VERBVerb Technology Company Inc
$ 13.4687
(70.27%)
21.49M
XPONExpion360 Inc
$ 3.64
(52.30%)
23.66M
LBPHLongboard Pharmaceuticals Inc
$ 58.79
(51.13%)
25.2M
RANIRani Therapeutics Holdings Inc
$ 2.771
(37.18%)
26.7M
MTEMMolecular Templates Inc
$ 0.3349
(-77.22%)
3M
ZPTAZapata Computing Holdings Inc
$ 0.0774
(-70.34%)
25.76M
SPPLSIMPPLE Ltd
$ 0.327
(-31.88%)
337.65k
VEVVicinity Motor Corporation
$ 0.081
(-30.83%)
3.44M
HUBCWHub Cyber Security Ltd
$ 0.0095
(-26.36%)
2.05k
TVGNTevogen Bio Holdings Inc
$ 1.18
(210.85%)
153.43M
NVDANVIDIA Corporation
$ 139.12
(3.20%)
90.03M
JTAIJet AI Inc
$ 0.1137
(12.57%)
72.15M
SQQQProShares UltraPro Short QQQ
$ 6.9901
(-2.51%)
50.52M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 9.4788
(0.84%)
46.09M

Your Recent History

Delayed Upgrade Clock